Real-World Experience With Efgartigimod in CIDPByKarissa Gable, MD ,Jeffrey Allen, MD August 19th 2026
What Achieving an INCAT Score of 0 or 1 Means for Patients With CIDPByKarissa Gable, MD ,Jeffrey Allen, MD August 12th 2026
Interpreting the ADHERE and ADHERE+ Post Hoc AnalysisByKarissa Gable, MD ,Jeffrey Allen, MD August 5th 2026
Understanding the Clinical Value of the INCAT Disability ScoreByKarissa Gable, MD ,Jeffrey Allen, MD July 29th 2026